CIK: 0001602263
申报总市值
US$3.8亿
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Avexis INC | 股票-其他 | 30.74% | — | — | |
| 2 | BHVN | Biohaven Ltd. | 股票-其他 | 15.15% | -4.69% | — | |
| 3 | ASND | Ascendis Pharma A/S | 股票-其他 | 10.94% | -8.61% | EXIT | |
| 4 | EWTX | Edgewise Therapeutics, Inc. | 股票-其他 | 7.92% | — | — | |
| 5 | ✓ | DBV Technologies | 股票-其他 | 7.56% | — | — | |
| 6 | RARXEUR | Ra Pharmaceuticals INC | 股票-其他 | 5.76% | -6.10% | EXIT | |
| 7 | BCRX | Biocryst Pharmaceuticals INC | 股票-其他 | 5.50% | -3.14% | EXIT | |
| 8 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 5.44% | — | — | |
| 9 | ✓ | Axovant Sciences LTD | 股票-其他 | 2.79% | — | -29.77% | |
| 10 | XLRN | Acceleron Pharma INC | 股票-其他 | 1.90% | — | — | |
| 11 | CTMX | Cytomx Therapeutics INC | 股票-其他 | 1.79% | — | — | |
| 12 | ✓ | ARCA biopharma Inc | 股票-其他 | 1.03% | — | — | |
| 13 | ✓ | 股票-其他 | 0.78% | — | +15.37% | ||
| 14 | 4XC1 | Kalvista Pharmaceuticals INC | 股票-其他 | 0.65% | +0.05% | — | |
| 15 | ✓ | Lipocine INC New | 股票-其他 | 0.62% | — | -7.87% | |
| 16 | ✓ | Ocera Therapeutics INC | 股票-其他 | 0.56% | — | — | |
| 17 | ✓ | Obseva SA | 股票-其他 | 0.51% | -5.57% | — | |
| 18 | ADVMCHF | Adverum Biotechnologies INC | 股票-其他 | 0.28% | +1.16% | NEW | |
| 19 | SRRAEUR | Sierra Oncology INC | 股票-其他 | 0.06% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | +1.6% | +21.57% | 加仓 |
| 2 | EWTX | Edgewise Therapeutics, Inc. | +0.7% | — | 不变 |
| 3 | XLRN | Acceleron Pharma INC | +0.2% | — | 不变 |
| 4 | ✓ | Axovant Sciences LTD | +0.2% | -29.77% | 减仓 |
| 5 | SRRAEUR | Sierra Oncology INC | 0% | — | 不变 |
| 6 | 4XC1 | Kalvista Pharmaceuticals INC | 0% | — | 不变 |
| 7 | ADVMCHF | Adverum Biotechnologies INC | 0% | — | 不变 |
| 8 | ✓ | Lipocine INC New | -0.1% | -7.87% | 减仓 |
| 9 | ✓ | DBV Technologies | -0.1% | — | 不变 |
| 10 | ✓ | Ocera Therapeutics INC | -0.1% | — | 不变 |
| 11 | ✓ | ARCA biopharma Inc | -0.1% | — | 不变 |
| 12 | CTMX | Cytomx Therapeutics INC | -0.3% | — | 不变 |
| 13 | RARXEUR | Ra Pharmaceuticals INC | -0.6% | +6.17% | 加仓 |
| 14 | ✓ | -0.9% | +15.37% | 加仓 | |
| 15 | ✓ | Avexis INC | -1.5% | — | 不变 |
| 16 | BCRX | Biocryst Pharmaceuticals INC | -15.4% | -59.23% | 减仓 |
| 17 | BHVN | Biohaven Ltd. | — | NEW | 新建仓 |
| 18 | ARGX | Argenx Se - Adr | — | NEW | 新建仓 |
| 19 | BOLDEUR | Audentes Therapeutics INC | — | EXIT | 清仓 |
| 20 | CHRS | Coherus Oncology INC | — | EXIT | 清仓 |
| 21 | STMLEUR | Stemline Therapeutics INC | — | EXIT | 清仓 |
| 22 | ✓ | Obseva SA | — | NEW | 新建仓 |
| 23 | ✓ | Alcobra Ltd | — | EXIT | 清仓 |